Dr David Erritzoe

Publications


Journals

  • Erritzoe D; Frokjaer VG; Holst KK; Christoffersen M; Johansen SS; Svarer C; Madsen J; Rasmussen PM; et alRamsøy T; Jernigan TL; Knudsen GM. (Jun 2011). In vivo imaging of cerebral serotonin transporter and serotonin(2A) receptor binding in 3,4-methylenedioxymethamphetamine (MDMA or "ecstasy") and hallucinogen users. Arch Gen Psychiatry. 68:562-576. DOI.

Conferences

  • Erritzoe D; Tziortzi A; Bargiela D; Searle G; Gunn RN; Beaver JD; Waldman A; Nutt D; et alBani M; Merlo-Pich E; Rabiner EA; Lingford-Hughes A. In Vivo Imaging of Dopamine D3 Receptors in Alcoholism Using Positron Emission Tomography, [11C]PHNO, and a Selective D3 Receptor Antagonist. 66th Annual Meeting of the Society-of-Biological-Psychiatry, 12 May 2011 - 14 May 2011. 69:271S-271S. ELSEVIER SCIENCE INC (1 May 2011). Author weblink.
  • Erritzoe D; Frokjaer VG; Licht CL; Christoffersen M; Baare W; Ramsoy TZ; Svarer C; Jermgan T; et alKnudsen GM. SIMULTANEOUS POLYSUBSTANCE USE AND SEROTONIN TRANSPORTER AND 2A RECEPTOR BINDING AMONG HUMAN MDMA AND HALLUCINOGEN USERS. Summer Meeting of the British-Association-for-Psychopharmacology, 25 Jul 2010 - 28 Jul 2010. 24:A58-A58. SAGE PUBLICATIONS LTD (1 Aug 2010).
Share this on Delicious
Tweet this
Digg this
Stumble this
Share this on Facebook